Advertisement
Advertisement
PTHS
Pelthos Therapeutics Inc.
25.50
USDSponsored
+0.46
+1.86%
May 08, 15:58 UTC -4
Closed
After-Market
25.50
0.00
0.00%
PTHS Earnings Reports
Positive Surprise Ratio
PTHS beat 2 of 6 last estimates.
33%
Next Report
In 4 Days
Date of Next Report
May 14, 2026
Estimate for Q1 26 (Revenue/ EPS)
$10.65M
/-$3.34
Implied change from Q4 25 (Revenue/ EPS)
+13.48%
/+65.35%
Implied change from Q1 25 (Revenue/ EPS)
--
/--
Pelthos Therapeutics Inc. earnings per share and revenue
On Mar 19, 2026, PTHS reported earnings of -2.02 USD per share (EPS) for Q4 25, beating the estimate of -4.21 USD, resulting in a 51.81% surprise. Revenue reached 9.39 million, compared to an expected 9.27 million, with a 1.26% difference. The market reacted with a -4.62% price change (close before vs. close after earnings).
Looking ahead to Q1 26, -- analysts forecast an EPS of -3.34 USD, with revenue projected to reach 10.65 million USD, implying an increase of 65.35% EPS, and increase of 13.48% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
FAQ
What were Pelthos Therapeutics Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Pelthos Therapeutics Inc. reported EPS of -$2.02, beating estimates by 51.81%, and revenue of $9.39M, 1.26% above expectations.
How did the market react to Pelthos Therapeutics Inc.'s Q4 2025 earnings?
The stock price moved down -4.62%, changed from $24.08 before the earnings release to $22.97 the day after.
When is Pelthos Therapeutics Inc. expected to report next?
The next earning report is scheduled for May 14, 2026.
What are the forecasts for Pelthos Therapeutics Inc.'s next earnings report?
Based on --
analysts, Pelthos Therapeutics Inc. is expected to report EPS of -$3.34 and revenue of $10.65M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement